帕金森病DBS治疗后的药物管理  

Medication after deep brain stimulation operation in Parkinson's disease

作　　者：陈玲[1] 

机构地区：[1]中山大学附属第一医院神经科,广州510080

出　　处：《重庆医科大学学报》2017年第6期655-658,共4页Journal of Chongqing Medical University

摘　　要：帕金森病脑深部电刺激(deep brain stimulation,DBS)术后药物管理需与程控相结合。本文总结了DBS术后1年内到最长15年的用药情况,控制运动症状以减药为主,改善非运动症状可沿用术前药物。Medication should be combined with programming in patients with Parkinson＇s disease after deep brain stimulation（DBS）surgery. This article summarizes postoperation medication from less than one year to fifteen years in Parkinsonian patients receiving DBS. Levodopa equivalent daily dosage（LEDD）should be reduced in controlling motor symptoms. Drugs used to improve non-motor symptoms might be similar with that preoperation.

关 键 词：帕金森病 脑深部电刺激 底丘脑核 长期随访 药物管理 

分 类 号：R743.35[医药卫生—神经病学与精神病学]